Mark Cuban's Cost Plus Drugs proves that bypassing insurers can dramatically lower costs through direct, transparent pricing. To that extent, it should be praised. But true disruption requires challenging not just PBMs and insurers, but also the assumption that comprehensive insurance is the best way to pay for everyday care. Until that idea changes, efforts to improve affordability and transparency will remain constrained.
President Adams signed into law an act requiring that twenty cents per month be deducted from the wages of private merchant sailors and paid into a federal fund for their medical care. It is sometimes described as America’s first health insurance mandate, but in truth it is not strong evidence that the founders would approve of today's calls for government involvement in healthcare.
The No Surprises Act eliminated surprise medical bills by replacing balance billing with a government-run arbitration process. But without transparent, market-based healthcare prices, arbitrators have no objective basis for determining fair payment rates. Lasting reform requires restoring price transparency and expanding direct-pay healthcare markets that allow real price discovery and consumer choice.
Section 6001 of the Affordable Care Act effectively prevents new physician-owned hospitals from participating in Medicare, dramatically limiting their growth. The debate over repeal reveals deeper questions about corporate versus physician ownership, subsidy-seeking, taxpayer interests, and whether government policies have distorted healthcare markets in ways that undermine genuine competition and patient choice.
Medicaid fraud is highly concerning, but the federal crackdown on the issue misses a deeper problem: rules that punish honest providers and disempower patients. Instead of relying solely on AI and aggressive enforcement, policymakers should expand cash-pay options, permit parallel practice, and give patients greater control over healthcare dollars to build a system that rewards integrity.
The current FDA review process generates a single decision that everyone must abide by. What if instead we adopted a more permissive approach for drugs entering the private market, and stricter review (including cost) for drugs seeking coverage by public payers? This acknowledges the difference between private and public, and would expand patient choice while protecting taxpayers and reducing political pressure on regulators.
When patients lose the power to shape healthcare with their own dollars, profits stop serving patients and start serving regulations. From Certificate of Need laws to prior authorizations, government interventions often distort incentives, while freer models like Direct Primary Care and Cost Plus Drugs show how profits can align with patient interests.
Americans are often told that healthcare corporations restrict patient choice and drive up costs in pursuit of profit. But the deeper problem is the dominance of comprehensive health insurance itself. By financing routine care through insurance, the system disconnects patients from prices and limits their ability to reward affordable care. Expanding alternatives to comprehensive health insurance could restore competition and affordability.
Concerns about English proficiency often arise in debates over reforming the way that we allow foreign-trained physicians to apply for a medical license. Evidence shows they perform comparably to U.S. graduates, with safeguards minimizing risks. Published research does not show a systematic link between limited English proficiency and worse outcomes, suggesting such concerns should not block reform efforts.
Vermont Senate Bill 142 expands access to care by removing barriers to licensure for qualified, foreign-trained physicians who seek to practice in the state. It builds on existing safeguards for credentialing and oversight while shifting evaluation to real-world clinical performance, addressing concerns about verification, background checks, and patient safety, and strengthening access to timely care.
Vermont Senate Bill 142 introduces a much-needed licensing reform that lets qualified foreign-trained physicians practice without repeating residency. One parameter that is currently being debated is the recency-of-practice standard. A flexible standard such as 1 year in the past 7 years makes the most of this opportunity to expand access, reduce licensing barriers, and help more doctors serve patients.
Advances in medicine are multiplying the ways people can pursue health, from cautious minimalism to aggressive experimentation. As preferences diverge, one-size-fits-all insurance and paternalistic policy strain to keep up. A more pluralist approach that lets individuals choose their path and bear the associated costs would reduce conflict and better support innovation and freedom in healthcare.
